Police & Firemen s Retirement System of New Jersey Has $9.38 Million Stake in Axon Enterprise, Inc $AXON

Police & Firemen s Retirement System of New Jersey raised its position in shares of Axon Enterprise, Inc (NASDAQ:AXON) by 7.2% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 11,326 shares of the biotechnology company’s stock after acquiring an additional 762 shares during the quarter. Police & Firemen s Retirement System of New Jersey’s holdings in Axon Enterprise were worth $9,377,000 as of its most recent SEC filing.

A number of other large investors have also recently bought and sold shares of AXON. TCTC Holdings LLC lifted its stake in shares of Axon Enterprise by 75.0% in the 1st quarter. TCTC Holdings LLC now owns 56 shares of the biotechnology company’s stock valued at $29,000 after purchasing an additional 24 shares during the period. Banque Transatlantique SA bought a new stake in Axon Enterprise in the first quarter worth approximately $31,000. Flaharty Asset Management LLC acquired a new position in Axon Enterprise in the first quarter valued at approximately $33,000. Hemington Wealth Management lifted its stake in Axon Enterprise by 70.8% in the second quarter. Hemington Wealth Management now owns 41 shares of the biotechnology company’s stock valued at $33,000 after buying an additional 17 shares during the period. Finally, Whipplewood Advisors LLC boosted its holdings in shares of Axon Enterprise by 192.9% during the 2nd quarter. Whipplewood Advisors LLC now owns 41 shares of the biotechnology company’s stock worth $34,000 after buying an additional 27 shares in the last quarter. 79.08% of the stock is currently owned by institutional investors and hedge funds.

Axon Enterprise Stock Down 2.1%

AXON opened at $557.29 on Friday. Axon Enterprise, Inc has a fifty-two week low of $469.24 and a fifty-two week high of $885.91. The firm has a market capitalization of $43.98 billion, a P/E ratio of 137.60, a PEG ratio of 29.49 and a beta of 1.45. The company’s 50-day moving average is $706.36 and its 200 day moving average is $734.49. The company has a debt-to-equity ratio of 0.63, a current ratio of 2.95 and a quick ratio of 2.71.

Axon Enterprise (NASDAQ:AXON) last issued its quarterly earnings data on Wednesday, November 5th. The biotechnology company reported $1.17 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.63 by ($0.46). The firm had revenue of $710.64 million during the quarter, compared to the consensus estimate of $704.83 million. Axon Enterprise had a return on equity of 6.80% and a net margin of 13.64%.The company’s revenue for the quarter was up 30.6% on a year-over-year basis. During the same period in the previous year, the company posted $1.45 earnings per share. Research analysts expect that Axon Enterprise, Inc will post 5.8 earnings per share for the current fiscal year.

Analyst Ratings Changes

AXON has been the subject of several research analyst reports. Weiss Ratings reiterated a “hold (c)” rating on shares of Axon Enterprise in a research note on Wednesday, October 8th. Cowen reaffirmed a “buy” rating on shares of Axon Enterprise in a research note on Wednesday, November 5th. Northland Securities set a $800.00 price objective on shares of Axon Enterprise in a research report on Tuesday, August 5th. Bank of America raised their target price on Axon Enterprise from $895.00 to $1,000.00 and gave the company a “buy” rating in a research note on Wednesday, August 6th. Finally, Raymond James Financial reaffirmed an “outperform” rating and set a $855.00 price target (up from $645.00) on shares of Axon Enterprise in a research note on Tuesday, August 5th. Fourteen analysts have rated the stock with a Buy rating and four have given a Hold rating to the stock. According to data from MarketBeat.com, Axon Enterprise presently has a consensus rating of “Moderate Buy” and an average target price of $810.71.

Insiders Place Their Bets

In other Axon Enterprise news, Director Jeri Williams sold 100 shares of the business’s stock in a transaction on Thursday, September 11th. The stock was sold at an average price of $752.54, for a total value of $75,254.00. Following the transaction, the director owned 1,416 shares of the company’s stock, valued at approximately $1,065,596.64. The trade was a 6.60% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CFO Brittany Bagley sold 5,000 shares of the company’s stock in a transaction on Monday, September 29th. The shares were sold at an average price of $713.88, for a total value of $3,569,400.00. Following the completion of the transaction, the chief financial officer owned 93,592 shares of the company’s stock, valued at $66,813,456.96. This trade represents a 5.07% decrease in their position. The SEC filing for this sale provides additional information. In the last three months, insiders sold 38,622 shares of company stock valued at $26,439,364. Insiders own 5.70% of the company’s stock.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.